Clinical Trial Update: Safety of MT-401-OTS in Patients With Relapsed AML or MDS [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update assessing the safety of MT-401-OTS in patients with relapsed acute myeloid leukemia or myelodysplastic syndrome, currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• MT-401-OTS

Snippet

Sponsor: Marker Therapeutics, Inc. | Conditions: Acute Myeloid Leukemia, in Relapse, MDS | Phase 1 | Status: RECRUITING